Results 241 to 250 of about 5,326,178 (309)

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin   +11 more
wiley   +1 more source

Diagnostic and prognostic utility of serum β-synuclein in Alzheimer's disease: a longitudinal cohort study. [PDF]

open access: yesJ Prev Alzheimers Dis
Xie S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy